Carlos Silva

Prof. Dr. Carlos Silva

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2019 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
Carlos SilvaCarlos Silva
Carlos Silva
RDRoberto Domínguez
Roberto Domínguez

9 January 2020 in Experimental Physiology
Verified
Journal Article
Closed access
PDF file
Carlos SilvaCarlos Silva
Carlos Silva
GCGeorgina Daniela Cortés
Georgina Daniela Cortés
CJCintia Yolanda Javier
Cintia Yolanda Javier
AFAngélica Flores
Angélica Flores
RDRoberto Domínguez
Roberto Domínguez

18 August 2025 in Molecules
Verified
Journal Article
Open access
PDF file
EVElizabeth Vieyra Valdez
Elizabeth Vieyra Valdez
Carlos SilvaCarlos Silva
Carlos Silva
RLRosa Linares
Rosa Linares
GRGabriela Rosas
Gabriela Rosas
JEJulieta A Espinoza Azucena Espinoza
Julieta A Espinoza Azucena Espinoza
LMLeticia Morales-Ledesma
Leticia Morales-Ledesma
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder characterized by a clinical and/or biochemical hyperandrogenism. In addition, PCOS is also associated with the presence of ovarian cysts, anovulation, and menstrual abnormalities such as oligomenorrhea or amenorrhea. The aetiology of the syndrome is multifactorial and heterogeneous due to the interaction of genetic, hormonal, metabolic, and environmental factors, as well as the different phenotypes and responses to treatments exhibited by the patients. Considering this complex interaction, it is essential to continue with the research focused on the mechanisms involved in the development and maintenance of the pathology. The alteration in the pulsatile secretion of the gonadotropin-releasing hormone (GnRH) is considered to be one of the main causes that contributes to its onset. In this review, we discuss recent evidence about the role of the rostral periventricular area of the third ventricle (RP3V), the arcuate nucleus (ARC), and the ventromedial nucleus of the hypothalamus (VMH), key hypothalamic regions that regulate GnRH secretion, in the development of PCOS. In addition, we analyse the clinical, metabolic, and endocrine factors that interact in the patients with PCOS, offering a multifactorial perspective to improve our understanding of this disorder.

17 August 2024 in Molecular Biology Reports
Verified
Journal Article
Open access
PDF file
JRJessica Romero-Reyes
Jessica Romero-Reyes
EVEDGAR RICARDO VAZQUEZ-MARTINEZ
EDGAR RICARDO VAZQUEZ-MARTINEZ
Carlos SilvaCarlos Silva
Carlos Silva
AMAnayansi Molina-Hernández
Anayansi Molina-Hernández
NDNestor Diaz
Nestor Diaz
ICIgnacio Camacho-Arroyo
Ignacio Camacho-Arroyo
Glioblastoma is the most aggressive brain cancer with an unfavorable prognosis for patient survival. Glioma stem cells, a subpopulation of cancer cells, drive tumor initiation, self-renewal, and resistance to therapy and, together with the microenvironment, play a crucial role in glioblastoma maintenance and progression. Neurotransmitters such as noradrenaline, dopamine, and serotonin have contrasting effects on glioblastoma development, stimulating or inhibiting its progression depending on the cellular context and through their action on glioma stem cells, perhaps changing the epigenetic landscape. Recent studies have revealed that serotonin and dopamine induce chromatin modifications related to transcriptional plasticity in the mammalian brain and possibly in glioblastoma; however, this topic still needs to be explored because of its potential implications for glioblastoma treatment. Also, it is essential to consider that neurotransmitters’ effects depend on the tumor’s microenvironment since it can significantly influence the response and behavior of cancer cells. This review examines the possible role of neurotransmitters as regulators of glioblastoma development, focusing on their impact on the chromatin of glioma stem cells.

8 November 2023 in Reproduction
Verified
Journal Article
Closed access
PDF file
Carlos SilvaCarlos Silva
Carlos Silva
DBDiana Pamela Benítez
Diana Pamela Benítez
AFAngélica Flores
Angélica Flores
GCGeorgina Daniela Cortés
Georgina Daniela Cortés
EVElizabeth Vieyra
Elizabeth Vieyra
RDRoberto Domínguez
Roberto Domínguez
: In brief: The SCN regulates ovulation by stimulating the preovulatory surge of gonadotropins. This study revealed an additional role in the sensitization of the hypothalamus to estradiol that changes along the estrous cycle and the side of the nucleus. Ovulation is timed by neural signals originating at the suprachiasmatic nucleus (SCN) that trigger ovulation when converge with high estradiol levels, which indicates the maturation of ovarian follicles. We have shown that the hypothalamic regulation of ovulation is asymmetrical and we hypothesized that the paired SCN could contribute to such symmetries. We unilaterally lesioned the SCN of rats at each stage of the estrous cycle and evaluated the acute effects on the progression of their estrous cycle, follicular development and ovulation. Lesions prevented progression of the estrous cycle when performed in estrus/metestrus but not in diestrus/proestrus. Abnormalities in follicular development were observed in the nonovulating lesioned rats and this was independent of the side of the SCN destroyed and the stage of the cycle when surgery was performed. Groups of lesioned rats were then hormonally primed with GnRH or estradiol to assess the neuroendocrine pathway altered by the treatment. GnRH restored ovulation, suggesting that both SCN are needed for proper triggering of the preovulatory surge of GnRH and that unilateral lesion does not impair the sensitivity of the pituitary or the ovary to GnRH and gonadotropins, respectively. With regard to restoring ovulation, estradiol was asymmetrically effective in rats lesioned in estrous, partially effective in rats operated at diestrus and ineffective in rats at metestrus. Our results indicate that the SCN regulates the activity of the hypothalamic–pituitary–ovarian axis not only by modulating the preovulatory surge of GnRH/gonadotropins but also by promoting the hypothalamic integration of estrogenic signals from the ovaries in an asymmetric and stage-dependent fashion.

3 June 2024 in Journal of Neuroendocrinology
Verified
Journal Article
Open access
EVElizabeth Vieyra
Elizabeth Vieyra
RCRoberto Calderón
Roberto Calderón
RLRosa Linares
Rosa Linares
GRGabriela Rosas
Gabriela Rosas
DRDeyra A. Ramírez
Deyra A. Ramírez
LMLeticia Morales
Leticia Morales
Reproduction in all mammalian species depends on the growth and maturation of ovarian follicles, that is, folliculogenesis. Follicular development can culminate with the rupture of mature follicles and the consequent expulsion of their oocytes (ovulation) or in atresia, characterized by the arrest of development and eventual degeneration. These processes are regulated by different neuroendocrine signals arising at different hypothalamic nuclei, including the suprachiasmatic nucleus (SCN). In the later, the activation of muscarinic receptors (mAChRs) and nicotinic receptors (nAChRs) by acetylcholine is essential for the regulation of the pre‐ovulatory signals that stimulate the rupture of mature follicles. To evaluate the participation of the nAChRs in the SCN throughout the oestrous cycle in the regulation of the hypothalamic–pituitary–ovarian axis. For this purpose, 90‐day‐old adult female rats in metoestrus, dioestrus, proestrus or oestrus were microinjected into the left‐ or right‐SCN with 0.3 μL of saline solution as vehicle or with 0.225 μg of mecamylamine (Mec), a non‐selective antagonist of the nicotinic receptors, diluted in 0.3 μL of vehicle. The animals were sacrificed when they presented vaginal cornification, indicative of oestrus stage, and the effects of the unilateral pharmacological blockade of the nAChRs in the SCN on follicular development, ovulation and secretion of oestradiol and follicle‐stimulating hormone (FSH) were evaluated. The microinjection of Mec decreased the serum levels of FSH, which resulted in a lower number of growing and healthy follicles and an increase in atresia. The higher percentage of atresia in pre‐ovulatory follicles was related to a decrease in the number of ova shed and abnormalities in oestradiol secretion. We also detected asymmetric responses between the left and right treatments that depended on the stage of the oestrous cycle. The present results allow us to suggest that during all the stages of the oestrous cycle, cholinergic signals that act on the nAChRs in the SCN are pivotal to modulate the secretion of gonadotropins and hence the physiology of the ovaries. Further research is needed to determine if such signals are generated by the cholinergic neurons in the SCN or by cholinergic afferents to the SCN.